Buscar
Mostrando ítems 31-40 de 4932
Efectos del ejercicio físico y pautas básicas para su prescripción en la enfermedad de Alzheimer
(2016-03-01)
The aim of this study is to update the state of the art regarding the potential benefits of physical exercise on Alzheimer's disease. Firstly, the reasons why physical exercise may be beneficial are discussed through the ...
Doença de Alzheimer: estudo da mortalidade no Brasil, 2000-2009Mortality from Alzheimer’s disease in Brazil, 2000-2009Enfermedad de Alzheimer: estudio de la mortalidad en Brasil, 2000-2009
(Escola Nacional de Saúde Pública Sérgio Arouca, 2018)
Early evaluation of Alzheimer's disease: Biomarkers and neuropsychological tests Evaluación de la enfermedad de Alzheimer en etapa temprana: Biomarcadores y pruebas neuropsicológicas
(2012)
Alzheimer disease is a neurodegenerative condition that affects cognitive, behavioral and global functioning of patients. Currently and due to the lack of conclusive biological testing, Alzheimer's disease diagnosis is ...
Mild cognitive impairment and the onset of Alzheimer's disease in older adults Deterioro cognitivo leve y enfermedad de Alzheimer inicial en adultos mayores
(2001)
The early detection of dementia carries implications for clinical management of patients and their families, and it is of utmost concern if an effective pharmacological treatment is to be found. We report the final clinical ...
Distinct attitudes of professionals from different medical specialties toward autonomy and legal instruments in the assessment of patients with Alzheimer's disease
(Associação de Neurologia Cognitiva e do Comportamento, 2010)
The evaluation of competence of Alzheimer's disease (AD) patients to assume personal or collective responsibilities and the resulting legal implications is a relevant issue.
Revisão integrativa: verificação da eficácia / efetividade da Cannabis medicinal e dos derivados canabinoides na Doença de AlzheimerIntegrative review: verification of efficacy / effectiveness of medical Cannabis and cannabinoid derivatives in Alzheimer's disease
(Fundação Oswaldo Cruz. Instituto de Tecnologia em Fármacos. Centro de Inovação em Biodiversidade e Saúde, 2022)
Metabolic abnormalities of erythrocytes as a risk factor for Alzheimer's disease
(Frontiers Media S.A., 2018)